$2.20
Clopitab A 150mg 10 Tablets is a cardiovascular antiplatelet combination designed to reduce platelet aggregation and support clot-risk management.
Clopitab A is a combination antiplatelet formulation generally containing Clopidogrel with Aspirin. Clopidogrel inhibits the P2Y12 ADP receptor on platelets, while aspirin reduces thromboxane-mediated platelet activation. Together they provide dual antiplatelet activity in appropriate clinical settings.
Common active ingredients: Clopidogrel + Aspirin
Stated strength: 150mg
Form: Tablet
Quantity: 10 tablets
Class: Antiplatelet combination
$2.20
Clopitab A 150mg 10 Tablets is a cardiovascular antiplatelet combination designed to reduce platelet aggregation and support clot-risk management.
Clopitab A is a combination antiplatelet formulation generally containing Clopidogrel with Aspirin. Clopidogrel inhibits the P2Y12 ADP receptor on platelets, while aspirin reduces thromboxane-mediated platelet activation. Together they provide dual antiplatelet activity in appropriate clinical settings.
Common active ingredients: Clopidogrel + Aspirin
Stated strength: 150mg
Form: Tablet
Quantity: 10 tablets
Class: Antiplatelet combination
There are no reviews yet.
$2.20
Clopitab A 150mg 10 Tablets is a cardiovascular antiplatelet combination designed to reduce platelet aggregation and support clot-risk management.
Clopitab A is a combination antiplatelet formulation generally containing Clopidogrel with Aspirin. Clopidogrel inhibits the P2Y12 ADP receptor on platelets, while aspirin reduces thromboxane-mediated platelet activation. Together they provide dual antiplatelet activity in appropriate clinical settings.
Common active ingredients: Clopidogrel + Aspirin
Stated strength: 150mg
Form: Tablet
Quantity: 10 tablets
Class: Antiplatelet combination
There are no reviews yet.
Reviews
There are no reviews yet.